Jennison Associates LLC has recently announced that it has increased stake in Argen X SE ADR (NASDAQ:ARGX) by 19.17%. After grabbing 1.8 million shares, the institutional investor is now in possession of 0.29 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 3.05% having worth around $811.8 million. Moreover, Capital Research & Management Co increased its share by 0.25 million to have a control over 1.43 million shares. And Massachusetts Financial Services raised its holdings to 0.45 million shares by acquiring 0.58 million shares or 0.98% of the stake.
Argen X SE ADR (ARGX) concluded trading on December 20, 2023 at a closing price of $338.91, with 5.41 million shares of worth about $1.83 billion changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -15.39% during that period and On Wednesday the price saw a loss of about -25.12%. Currently the company’s common shares owned by public are about 59.08M shares, out of which, 58.84M shares are available for trading.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
American Funds EuroPacific Growth, T Rowe Price New Horizons Fund, and T Rowe Price Health Sciences Fund are the top 3 mutual funds which are holding stakes in Argen X SE ADR American Funds EuroPacific Growth is currently holding 1.12 million shares of worth totaling $505.13 million. The company recently came buying 0.21 million shares which brought its stake up to 1.90% of the company’s outstanding shares. T Rowe Price New Horizons Fund bought 10126.0 shares, after which its hold over company’s outstanding shares expand to 1.83%, leaving 1.08 million shares with the mutual fund that have a worth of about $486.67 million. T Rowe Price Health Sciences Fund, after selling 0.71 million shares, have now control over 1.20% of the stake in the company. It holds 33429.0 shares of worth $319.28 million.
However, the stock later moved at a day high price of 346.79, or with a loss of -25.12%. Stock saw a price change of -26.56% in past 5 days and over the past one month there was a price change of -30.74%. Year-to-date (YTD), ARGX shares are showing a performance of -10.54% which decreased to -10.18% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $333.07 but also hit the highest price of $550.76 during that period. The average intraday trading volume for Argen X SE ADR shares is 270.00K. The stock is currently trading -26.64% below its 20-day simple moving average (SMA20), while that difference is down -28.92% for SMA50 and it goes to -23.63% lower than SMA200.
Jennison Associates LLC acquired 1.8 million shares of Argen X SE ADR having value of about $811.8 million. Data submitted at the U.S SEC by Jennison Associates LLC revealed that the firm now holds 0.29 million shares in the company valued at close to $98221879.47, or have control over 19.17% stake in the company. Argen X SE ADR (NASDAQ: ARGX) currently have 59.08M outstanding shares and institutions hold larger chunk of about 55.29% of that. Holding of mutual funds in the company is about 25.48% while other institutional holders and individual stake holders have control over 29.83% and — of the stake respectively.
The stock has a current market capitalization of $20.02B and its 3Y-monthly beta is at 0.73. It has posted earnings per share of -$7.17 in the same period. It has Quick Ratio of 7.84 while making debt-to-equity ratio of 0.00. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ARGX, volatility over the week remained 2.29% while standing at 2.19% over the month.
Analysts are in expectations that Argen X SE ADR (ARGX) stock would likely to be making an EPS of $Ardelyx, Inc. in the current quarter, while forecast for next quarter EPS is $5.94 and it is $Stocks for next year. For the current quarter EPS, analysts have given the company a lowest target $argenx SE which is $Agile Therapeutics, Inc. at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of $ARK Space Exploration & Innovat in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 63.98% while it is estimated to increase by 70.35% in next year.
